Literature DB >> 22576890

Update on a patient with superficial siderosis on deferiprone.

M Levy1, R H Llinas.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22576890      PMCID： PMC8013263          DOI： 10.3174/ajnr.A3186

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  7 in total

1.  [Superficial siderosis of the central nervous system caused by myxopapillary ependymoma of conus medullaris and cauda equine: a case report and literature review].

Authors:  L Xu; M J Hu; Y Y Li; H D Qu; W D Qian; X L Liu
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-08-18

2.  Two-year observational study of deferiprone in superficial siderosis.

Authors:  Remi A Kessler; Xu Li; Kateryna Schwartz; Hwa Huang; Maureen A Mealy; Michael Levy
Journal:  CNS Neurosci Ther       Date:  2017-12-28       Impact factor: 5.243

3.  Deferiprone Reduces Hemosiderin Deposition in Superficial Siderosis.

Authors:  Pei-Hsin Kuo; Sheng-Han Kuo; Raymond Y Lo
Journal:  Can J Neurol Sci       Date:  2016-10-28       Impact factor: 2.104

4.  Agranulocytosis with deferiprone treatment of superficial siderosis.

Authors:  Nikhil Huprikar; Marisa Gossweiler; Maureen Callaghan; Paul Bunge
Journal:  BMJ Case Rep       Date:  2013-08-07

Review 5.  Iron chelation and multiple sclerosis.

Authors:  Kelsey J Weigel; Sharon G Lynch; Steven M LeVine
Journal:  ASN Neuro       Date:  2014-01-30       Impact factor: 4.146

Review 6.  Recent Advances in the Treatment of Cerebellar Disorders.

Authors:  Hiroshi Mitoma; Mario Manto; Jordi Gandini
Journal:  Brain Sci       Date:  2019-12-23

7.  Treatment Response of Deferiprone in Infratentorial Superficial Siderosis: a Systematic Review.

Authors:  Andreas Flores Martin; Priya Shanmugarajah; Nigel Hoggard; Marios Hadjivassiliou
Journal:  Cerebellum       Date:  2021-01-06       Impact factor: 3.847
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.